Summit Therapeutics (SMMT) Ownership

SMMT$14.19—
BiotechnologyLarge CapGrowth Stock
Compare
Market cap$13.42BEnterprise value$12.77BRevenue (TTM)$0Market positionTop 25%

Score

67
Bullish
Value
53
Quality
47
Growth
100

Ownership data loads after the page opens.

Summit Therapeutics (SMMT) Ownership

SMMT price $14.19 —

Ticker
SMMT
Price
$14.19
Change
—
Market cap
$13.42B
Forward P/E
128.10
Dividend yield
0.00%
Beta
-1.24
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
67
Value
53
Quality
47
Growth
100

Stocklytics score rationale: value 53, quality 47, growth 100.

AI Score 25. Summit Therapeutics Inc. has a market cap of $12.79 billion but is currently unprofitable with a net income margin of 0 and a price-to-earnings ratio of -14.3

Insights · Forecast · Financials · Learn

Stocklytics home · Screener